Alembic Pharma gets USFDA nod for generic cancer treatment injection:

Alembic Pharma gets USFDA nod for generic cancer treatment injection:

Daily Current Affairs   /   Alembic Pharma gets USFDA nod for generic cancer treatment injection:

Change Language English Hindi

Category : Science and Tech Published on: July 02 2025

Share on facebook

Alembic Pharmaceuticals has secured final approval from the USFDA for its generic Doxorubicin Hydrochloride Liposome injection (20 mg/10 mL and 50 mg/25 mL). This key oncology treatment approval under ANDA allows Alembic to market a cost-effective alternative for various cancers in the US.

Recent Post's

  • Lieutenant General Susan Coyle appointed as first woman Chief of the Australian Army.

    Read More....

  • Ambedkar Jayanti and Baisakhi (April 14) celebrated together highlighting ideals of equality and social reform.

    Read More....

  • The Supreme Court dissolves Irretrievable Breakdown marriage under Article 142 and curbs misuse of legal process.

    Read More....

  • Bohag Bihu (Rongali Bihu) celebrations begin in Assam from April 14 to 20, 2026.

    Read More....

  • Sunil Bajpai appointed as Principal Chief Commissioner of Income Tax for Tamil Nadu & Puducherry.

    Read More....

  • Nitish Kumar resigns as Bihar Chief Minister; Samrat Choudhary to take over as new CM.

    Read More....

  • Mitchell Starc and Deepti Sharma named Leading Cricketers of the World by Wisden 2025.

    Read More....

  • NFDC to release Malayalam film ‘Achappa’s Album’ on 24 April 2026.

    Read More....

  • MoRTH notified new rules for overloaded vehicles on National Highways effective 15 April 2026.

    Read More....

  • NAAS organises brainstorming sessions to achieve Atmanirbharta in fertilizers by 2047.

    Read More....